Clinical and neuropsychological variables associated with subjective cognitive decline and its progression

Author:

Villino-Rodríguez Rafael1,Ríos-Rivera Mirla M.1,Imaz-Aguayo Laura2,Espinoza-Vinces Christian1,Pérez-Prol Cristina1,Montoya-Murillo Genoveva1,Arrondo Carlota1,Riverol Mario1

Affiliation:

1. Clínica Universidad de Navarra. Pamplona

2. Hospital Universitario de Navarra. Pamplona

Abstract

Abstract Background and Objectives: This study aimed to compare clinical and neuropsychological variables between patients with subjective cognitive decline (SCD) and healthy controls in a memory clinic, while identifying variables associated with progression to mild cognitive impairment (MCI) or dementia. Methods: We retrospectively analysed data from 945 patients with SCD and 68 healthy controls (HCs) who visited the Clínica Universidad de Navarra memory clinic between 2001 and 2017. Among them, 450 participants were followed up longitudinally in at least one visit until January 2020. All patients underwent medical interviews, laboratory tests, neuropsychological assessments (during the first interview and follow-ups) and brain magnetic resonance imaging. Of the 945 participants, 131 progressed to MCI or dementia due to Alzheimer’s disease. The neuropsychological assessment encompassed the following domains: cognitive functions (i.e. global cognition, episodic visual and verbal memory, executive functions, phonetic fluency, cognitive flexibility, interference and language), neuropsychiatric symptoms and functional status. All variables were adjusted for age, sex and education. Results: Participants with subjective cognitive decline were younger and had higher education than HCs. Additionally, they presented more vascular risk factors. Age at diagnosis, years of education and the presence of hypercholesterolemia were among the demographic variables that were positively associated with the development of MCI or dementia. In the neuropsychological assessment, individuals with SCD showed worse results in global cognition, verbal memory and semantic and phonetic fluency and exhibited more depressive symptoms. Moreover, exhibiting worse performance on tests evaluating episodic verbal memory was found to be correlated with an elevated likelihood of transitioning to MCI and dementia. Discussion: The development of SCD and its progression to MCI or dementia is a multifaceted process involving clinical and neuropsychological factors. Younger age and increased vascular risk factors are characteristics of individuals with SCD. Neuropsychologically, they tend to display weaker performance in global cognition, fluency tasks, verbal memory and executive functions. Several variables were identified as potential indicators of disease progression. These include age at diagnosis, hypercholesterolemia and poorer results in tests measuring semantic fluency, verbal and visual memory and executive functions.

Publisher

Research Square Platform LLC

Reference31 articles.

1. Scheltens P, Blennow K, Breteler MMB, de Strooper B, Frisoni GB, Salloway S, et al. Alzheimer’s disease. Vol. 388, The Lancet. Lancet Publishing Group; 2016. p. 505–17.

2. Dubois B, Feldman HH, Jacova C, DeKosky ST, Barberger-Gateau P, Cummings J, et al. Research criteria for the diagnosis of Alzheimer’s disease: revising the NINCDS–ADRDA criteria. Lancet Neurol [Internet]. 2007;6(8):734–46. Available from: https://linkinghub.elsevier.com/retrieve/pii/S1474442207701783

3. Toward defining the preclinical stages of Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease;Sperling RA;Alzheimer’s and Dementia,2011

4. The diagnosis of mild cognitive impairment due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease;Albert MS;Alzheimer’s and Dementia,2011

5. The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease;McKhann GM;Alzheimer’s and Dementia,2011

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3